Skip to content

Tomohiko Irie

2 papers in the library · 2 citations · publishing 2015-2022

Papers

Sort Most recent Most cited

Derivatives of methoxetamine and major methoxetamine metabolites potently block NMDA receptors.

Journal of Pharmacological Sciences December 1, 2022 Tomohiko Irie, Yuta Yanase, Yosuke Demizu et al. 2 citations

N-Methyl-D-aspartate receptors (NMDARs) in the brain are influenced by psychoactive drugs such as 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one (ketamine) and its analog 2-(ethylamino)-2-(3-methoxyphenyl)-cyclohexanone (methoxetamine). The recreational methoxetamine use can cause several toxicities and methoxetamine-related deaths have also been reported. Therefore, it has been banned in...

DOI: 10.1016/j.jphs.2022.09.005 (opens in new tab) Full text (opens in new tab) N-methyl-d-aspartate receptors Deoxymethoxetamine Methoxetamine metabolites Methoxisopropamine

MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors.

Neuropharmacology August 2015 Tomohiko Irie, Ruri Kikura-Hanajiri, Makoto Usami et al.

Herbal products containing synthetic cannabinoids-initially sold as legal alternatives to marijuana-have become major drugs of abuse. Among the synthetic cannabinoids, [1-(5-fluoropentyl)-1H-indol-3-yl](4-methyl-1-naphthalenyl)-methanone (MAM-2201) has been recently detected in herbal products and has psychoactive and intoxicating effects in humans, suggesting that MAM-2201 alters brain...

DOI: 10.1016/j.neuropharm.2015.02.025 (opens in new tab) Full text (opens in new tab) Cerebellum Mam-2201 Neurotransmitter release Purkinje cell +1